Local adverse effects of amalgam restorations

International Dental Journal

Volumn 58, Issue 1, 2008, Pages 3-9

  McCullough, M J ^a   Tyas, M J ^a,b  

^a University of Melbourne ^*

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adverse effects; Dental amalgam; Local effects; Systemic effects

Indexed keywords

EID: 39749098063     PISSN: 00206539     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1875-595X.2008.tb00170.x     Document Type: Review

References (91)

1. Craig R G, el-Ebrashi MK, LePeak PJ et al. Experimental stress analysis of dental restorations. I. Two-dimensional photoelastic stress analysis of inlays. J Prosthet Dent 1967 17: 277-291.
2. American Dental Association Council on Dental materials I a e. Dentists' Desk Reference: Materials, Instruments and Equipment. Second ed. 1983.
3. ADA Council on Scientific Affairs. Dental mercury hygiene recommendations. J Am Dent Assoc 2003 134: 1498-1499.
4. Tyas MJ. Placement and replacement of restorations by selected practitioners. Aust Dent J 2005 50: 81-89.
5. Dawson AS, Smales RJ. Restoration longevity in an Australian Defence Force population. Aust Dent J 1992 37: 196-200.
6. Forss H, Widstrom E. Reasons for restorative therapy and the longevity of restorations in adults. Acta Odontol Scand 2004 62: 82-86.
7. Burke FJ, Cheung SW, Mjör I A et al. Reasons for the placement and replacement of restorations in vocational training practices. Prim Dent Care 1999 6: 17-20.
8. Burke FJ, Liebler M, Eliades G et al. Ease of use versus clinical effectiveness of restorative materials. Quintessence Int 2001 32: 239-242.
9. Qvist J, Qvist V, Mjör IA. Placement and longevity of amalgam restorations in Denmark. Acta Odontol Scand 1990 48: 297-303.
10. Qvist V, Thylstrup A, Mjör IA. Restorative treatment pattern and longevity of amalgam restorations in Denmark. Acta Odontol Scand 1986 44: 343-349.
11. Mjör IA. The reasons for replacement and the age of failed restorations in general dental practice. Acta Odontol Scand 1997 55: 58-63.
12. Mjör IA, Dahl JE, Moorhead JE. Age of restorations at replacement in permanent teeth in general dental practice. Acta Odontol Scand 2000 58: 97-101.
13. Mjör IA, Moorhead JE. Selection of restorative materials, reasons for replacement, and longevity of restorations in Florida. J Am Coll Dent 1998 65: 27-33.
14. Mjör IA, Toffenetti F. Placement and replacement of amalgam restorations in Italy. Oper Dent 1992 17: 70-73.
15. Mjör IA, Um CM. Survey of amalgam and composite restorations in Korea. Int Dent J 1993 43: 311-316.
16. Hickel R, Manhart J. Longevity of restorations in posterior teeth and reasons for failure. J Adhes Dent 2001 3: 45-64.
17. Manhart J, Chen H, Hamm G et al. Buonocore Memorial Lecture. Review of the clinical survival of direct and indirect restorations in posterior teeth of the permanent dentition. Oper Dent 2004 29: 481-508.
18. Downer MC, Azli NA, Bedi R et al. How long do routine dental restorations last? A systematic review. Br Dent J 1999 187: 432-439.
19. Jokstad A, Mjör IA, Qvist V. The age of restorations in situ. Acta Odontol Scand 1994 52: 234-242.
20. Robbins JW. Evidence-based dentistry: what is it, and what does it have to do with practice? Anecdote vs. data - a case for evidence-based decision making. Quintessence Int 1998 29: 796-799.
21. Hawthorne WS, Smales RJ. Factors influencing long-term restoration survival in three private dental practices in Adelaide. Aust Dent J 1997 42: 59-63.
22. Balto H. An assessment of microbial coronal leakage of temporary filling materials in endodontically treated teeth. J Endod 2002 28: 762-764.
23. Craig RG, el-Ebrashi MK, LePeak PJ et al. Experimental stress analysis of dental restorations. I. Two-dimensional photoelastic stress analysis of inlays. J Prosthet Dent 1967 17: 277-291.
24. Craig RG, Zuroff M, Rosenberg PA. The effect of endodontic materials on periodontal ligament cell proliferation, alkaline phosphatase activity, and extracellular matrix protein synthesis in vitro. J Endod 1997 23: 494-498.
25. Haglund R, He J, Jarvis J et al. Effects of root-end filling materials on fibroblasts and macrophages in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003 95: 739-745.
26. Keiser K, Johnson CC, Tipton DA. Cytotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblasts. J Endod 2000 26: 288-291.
27. Osorio RM, Hefti A, Vertucci FJ et al. Cytotoxicity of endodontic materials. J Endod 1998 24: 91-96.
28. Tai KW, Chang YC. Cytotoxicity evaluation of perforation repair materials on human periodontal ligament cells in vitro. J Endod 2000 26: 395-357.
29. Torabinejad M, Hong CU, Pitt Ford TR et al. Cytotoxicity of four root end filling materials. J Endod 1995 21: 489-492.
30. Zhu Q, Safavi KE, Spangberg LS. Cytotoxic evaluation of root-end filling materials in cultures of human osteoblast-like cells and periodontal ligament cells. J Endod 1999 25: 410-412.
31. Zhu Q, Haglund R, Safavi KE et al. Adhesion of human osteoblasts on root-end filling materials. J Endod 2000 26: 404-406.
32. Makkawy HA, Koka S, Lavin MT et al. Cytotoxicity of root perforation repair materials. J Endod 1998 24: 477-479.
33. Owadally ID, Chong BS, Pitt Ford TR et al. Biological properties of IRM with the addition of hydroxyapatite as a retrograde root filling material. Endod Dent Traumatol 1994 10: 228-232.
34. Chong BS, Owadally ID, Pitt Ford TR et al. Cytotoxicity of potential retrograde root-filling materials. Endod Dent Traumatol 1994 10: 129-133.
35. Niederman R, Theodosopoulou JN. A systematic review of in vivo retrograde obturation materials. Int Endod J 2003 36: 577-585.
36. Buchner A, Hansen LS. Amalgam pigmentation amalgam tattoo of the oral mucosa. A clinicopathologic study of 268 cases. Oral Surg Oral Med Oral Pathol 1980 49: 139-147.
37. Buchner A. Amalgam tattoo, amalgam pigmentation, of the oral mucosa: clinical manifestations, diagnosis and treatment. Refuat Hapeh Vehashinayim 2004 21: 25-28, 92.
38. Forsell M, Larsson B, Ljungqvist A et al. Mercury content in amalgam tattoos of human oral mucosa and its relation to local tissue reactions. Eur J Oral Sci 1998 106: 582-587.
39. Aoyagi H, Katagiri M. Long-term effects of Ag-containing alloys on mucous tissue present in biopsy samples. Dent Mater J 2004 23: 340-347.
40. Mohr W, Gorz E. [Association of silver granules with elastic fibers in amalgam reaction of mouth mucosa]. HNO 2001 49: 454-457.
41. Eley BM. Tissue reactions to implanted dental amalgam, including assessment by energy dispersive x-ray micro-analysis. J Pathol 1982 138: 251-272.
42. Kirby AC, Olsen I, Farthing PM et al. Expression of lymphocyte function-associated antigen 3 in oral lichen planus. Oral Dis 1995 1: 193-197.
43. Triantafyllou A. Cytological and cytochemical investigations on granular cells in oral lichen planus. J Oral Pathol Med 1996 25: 151-156.
44. Farthing PM, Matear P, Cruchley AT. The activation of Langerhans cells in oral lichen planus. J Oral Pathol Med 1990 19: 81-85.
45. Scully C, Beyli M, Ferreiro MC et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998 9: 86-122.
46. Mattsson U, Jontell M, Holmstrup P. Oral lichen planus and malignant transformation: is a recall of patients justified? Crit Rev Oral Biol Med 2002 13: 390-396.
47. Hegarty AM, Hodgson TA, Lewsey JD et al. Fluticasone propionate spray and betamethasone sodium phosphate mouthrinse: a randomized crossover study for the treatment of symptomatic oral lichen planus. J Am Acad Dermatol 2002 47: 271-279.
48. Kaliakatsou F, Hodgson TA, Lewsey JD et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002 46: 35-41.
49. Lodi G, Porter SR. Hepatitis C virus infection and lichen planus: a short review. Oral Dis 1997 3: 77-81.
50. Sistig S, Vucicevic-Boras V, Lukac J et al. Salivary IgA and IgG subclasses in oral mucosal diseases. Oral Dis 2002 8: 282-286.
51. Simon M Jr., Gruschwitz MS. In situ expression and serum levels of tumour necrosis factor alpha receptors in patients with lichen planus. Acta Derm Venereol 1997 77: 191-193.
52. Thornhill MH. Immune mechanisms in oral lichen planus. Acta Odontol Scand 2001 59: 174-177.
53. Kawamura E, Nakamura S, Sasaki M et al. Accumulation of oligoclonal T cells in the infiltrating lymphocytes in oral lichen planus. J Oral Pathol Med 2003 32: 282-289.
54. Kallus T, Mjör IA. Incidence of adverse effects of dental materials. Scand J Dent Res 1991 99: 236-240.
55. Laine J, Konttinen YT, Beliaev N et al. Immunocompetent cells in amalgam-associated oral lichenoid contact lesions. J Oral Pathol Med 1999 28: 117-121.
56. Little MC, Watson RE, Pemberton MN et al. Activation of oral keratinocytes by mercuric chloride: relevance to dental amalgam-induced oral lichenoid reactions. Br J Dermatol 2001 144: 1024-1032.
57. 2·-induced human lymphocyte activation in vitro: a superantigenic mechanism? Int Arch Allergy Immunol 1999 120: 63-70.
58. Lundstrom IM. Allergy and corrosion of dental materials in patients with oral lichen planus. Int J Oral Surg 1984 13: 16-24.
59. Dunsche A, Kastel I, Terheyden H et al. Oral lichenoid reactions associated with amalgam: improvement after amalgam removal. Br J Dermatol 2003 148: 70-76.
60. Ostman PO, Anneroth G, Skoglund A. Oral lichen planus lesions in contact with amalgam fillings: a clinical, histologic, and immunohistochemical study. Scand J Dent Res 1994 102: 172-179.
61. Thornhill MH, Sankar V, Xu XJ et al. The role of histopathological characteristics in distinguishing amalgam-associated oral lichenoid reactions and oral lichen planus. J Oral Pathol Med 2006 35: 233-240.
62. Bolewska J, Reibel J. T lymphocytes, Langerhans cells and HLA-DR expression on keratinocytes in oral lesions associated with amalgam restorations. J Oral Pathol Med 1989 18: 525-528.
63. Jontell M, Stahlblad PA, Rosdahl I et al. HLA-DR3 antigens in erosive oral lichen planus, cutaneous lichen planus, and lichenoid reactions. Acta Odontol Scand 1987 45: 309-312.
64. James J, Ferguson MM, Forsyth A et al. Oral lichenoid reactions related to mercury sensitivity. Br J Oral Maxillofac Surg 1987 25: 474-480.
65. Nordlind K, Liden S. Patch test reactions to metal salts in patients with oral mucosal lesions associated with amalgam restorations. Contact Dermatitis 1992 27: 157-160.
66. Ostman PO, Anneroth G, Skoglund A. Amalgam-associated oral lichenoid reactions. Clinical and histologic changes after removal of amalgam fillings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996 81: 459-465.
67. Kanerva L, Rantanen T, Aalto-Korte K et al. A multicenter study of patch test reactions with dental screening series. Am J Contact Dermat 2001 12: 83-87.
68. van Noort R, Gjerdet NR, Schedle A et al. An overview of the current status of national reporting systems for adverse reactions to dental materials. J Dent 2004 32: 351-358.
69. Laeijendecker R, Dekker SK, Burger PM et al. Oral lichen planus and allergy to dental amalgam restorations. Arch Dermatol 2004 140: 1434-1438.
70. Henriksson E, Mattsson U, Hakansson J. Healing of lichenoid reactions following removal of amalgam. A clinical follow-up. J Clin Periodontol 1995 22: 287-294.
71. Thornhill MH, Pemberton MN, Simmons RK et al. Amalgam-contact hypersensitivity lesions and oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003 95: 291-299.
72. Sardella A, Lodi G, Demarosi F et al. Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments. Oral Dis 2006 12: 152-155.
73. Pigatto PD, Guzzi G, Persichini P et al. Recovery from mercury-induced burning mouth syndrome due to mercury allergy. Dermatitis 2004 15: 75-77.
74. Granot M, Nagler RM. Association between regional idiopathic neuropathy and salivary involvement as the possible mechanism for oral sensory complaints. J Pain 2005 6: 581-587.
75. Bergdahl BJ, Anneroth G, Anneroth I. Clinical study of patients with burning mouth. Scand J Dent Res 1994 102: 299-305.
76. Leao JC, Hodgson T, Scully C et al. Review article: orofacial granulomatosis. Aliment Pharmacol Ther 2004 15: 1019-1027.
77. Lazarov A, Kidron D, Tulchinsky Z et al. Contact orofacial granulomatosis caused by delayed hypersensitivity to gold and mercury. J Am Acad Dermatol 2003 49: 1117-1120.
78. Guttman-Yassky E, Weltfriend S, Bergman R. Resolution of orofacial granulomatosis with amalgam removal. J Eur Acad Dermatol Venereol 2003 17: 344-347.
79. Wray D, Rees SR, Gibson J et al. The role of allergy in oral mucosal diseases. QJM 2000 93:507-511.
80. Reinhardt JW Side-effects: mercury contribution to body burden from dental amalgam. Adv Dent Res 1992 6: 110-113.
81. Eley BM. The future of dental amalgam: a review of the literature. Part 6: Possible harmful effects of mercury from dental amalgam. Br Dent J 1997 182: 455-459.
82. Eley BM. The future of dental amalgam: a review of the literature. Part 5: Mercury in the urine, blood and body organs from amalgam fillings. Br Dent J 1997 182: 413-417.
83. Eley BM. The future of dental amalgam: a review of the literature. Part 4: Mercury exposure hazards and risk assessment. Br Dent J 1997 182: 373-381.
84. Eley BM. The future of dental amalgam: a review of the literature. Part 3: Mercury exposure from amalgam restorations in dental patients. Br Dent J 1997 182: 333-388.
85. Dental amalgam: update on safety concerns. ADA council on Scientific Affairs. J Am Dent Assoc 1998 129: 494-503.
86. FDI World. FDI World Dental Federation. WHO Consensus Statement on Dental Amalgam. 1997.
87. Mackert JR Jr., Berglund A. Mercury exposure from dental amalgam fillings: absorbed dose and the potential for adverse health effects. Crit Rev Oral Biol Med 1997 8: 410-436.
88. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med 2003 349: 1731-1737.
89. Brownawell AM, Berent S, Brent RL et al. The potential adverse health effects of dental amalgam. Toxicol Rev 2005 24: 1-10.
90. Bellinger DC, Trachtenberg F, Barregard L et al. Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial. JAMA 2006 295: 1775-1783.
91. DeRouen TA, Martin MD, Leroux BG et al. Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. JAMA 2006 295: 1784-1792.